- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/02 - Preparation by ring-closure or hydrogenation
Patent holdings for IPC class C07D 211/02
Total number of patents in this class: 88
10-year publication summary
|
8
|
4
|
5
|
11
|
5
|
3
|
2
|
2
|
4
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 20458 |
5 |
| Florida State University Research Foundation, Inc. | 711 |
4 |
| Theravance Biopharma R&D IP, LLC | 518 |
3 |
| Janssen Pharmaceutica N.V. | 3610 |
2 |
| Northwestern University | 3290 |
2 |
| Incyte Corporation | 968 |
2 |
| Incyte Holdings Corporation | 653 |
2 |
| MyCell Technologies, LLC | 6 |
2 |
| Nanyang Technological University | 1903 |
2 |
| OPKO Health, Inc. | 53 |
2 |
| Tesaro, Inc. | 105 |
2 |
| Unichem Laboratories Limited | 93 |
2 |
| Universite Claude Bernard Lyon 1 | 971 |
2 |
| Xinfa Pharmaceutical Co., Ltd. | 26 |
2 |
| Incyte Holdings Corporation and Incyte Corporation | 89 |
2 |
| Humanwell Pharmaceutical US | 7 |
2 |
| Merck Sharp & Dohme LLC | 3748 |
2 |
| L'OREAL, Société Anonyme | 15117 |
1 |
| Merck Sharp & Dohme Corp. | 2216 |
1 |
| Massachusetts Institute of Technology | 9930 |
1 |
| Other owners | 45 |